United States · 
Who invested in Diakonos Oncology?
Diakonos Oncology's investors include Revent.
United States · Funded startup
Who invested in Diakonos Oncology
Funding summaryUpdated 26 Oct 2026
$7.0Mraised across 1 round since 2025, from 1 source
- Latest round
- Grant, $7.0MDec 2025
- Investors
- 1
The rounds
- Dec 2025
Founders and team
From Diakonos Oncology's own website: 9 on the team.
- Jay HartenbachPresident, COO
- Donna RillCTO
- Deancy OkoeborVP of Clinical Operations
- Traci FontenotVP of Quality
- Dan FaustChairman
- Diakonos OncologyData Quality Analyst
- Kam SpotoClinical Trial Manager
- Nicole StarkData Quality Analyst
- Uday BandaruDirector of Quality
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Diakonos Oncology as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Diakonos Oncology
How much has Diakonos Oncology raised?
Diakonos Oncology has raised $7.0M across 1 round since 2025.
When did Diakonos Oncology last raise?
Diakonos Oncology's most recent round was a Grant of $7.0M in Dec 2025.
What was Diakonos Oncology's biggest round?
Its most recent round, $7.0M in Dec 2025, is also its largest on record.
Who backed Diakonos Oncology first?
Diakonos Oncology's first round on record, in Dec 2025, was backed by Revent.
What stage is Diakonos Oncology at?
Diakonos Oncology's latest named round is a Grant, in Dec 2025.
Where is Diakonos Oncology based?
Diakonos Oncology is based in the United States.
Companies like Diakonos Oncology
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.